Table 1.
Clinical characteristic of subjects
| Tumor type | Differentiation stage | Age | Sex | Tumor size (cm) | |
|---|---|---|---|---|---|
| NSCLC | T2N0M0 | III | 63 | M | 4*3*2 |
| T1N0M0 | IA | 51 | M | 2*2*1 | |
| T3N0M0 | IIB | 58 | M | 7*6*2 | |
| T2N1M0 | IIB | 68 | F | 5*4.5*4 | |
| T1N0M0 | II | 59 | M | 2.5*1.5*1.2 | |
| T2N0M0 | IB | 48 | M | 3.5*3*3 | |
| T2N0MO | IB | 52 | M | 1.6*1.6*1.5 | |
| T2N0M0 | IB | 64 | M | 3.5*3*2.5 | |
| T2N0M0 | IIA | 49 | F | 4.5*5*3 | |
| SCLC | T2N2M0 | IIIA | 54 | F | 4*2*2 |
Notes: Classification of the lung tumor samples used in the current studies. Total RNA and protein samples from lung tumors and their matching non-tumor control were obtained from The First Affiliated Hospital, Nanjing Medical University.